Wearable Neurorehabilitation Devices Market

Wearable Neurorehabilitation Devices Market (Application: Stroke, Spinal Cord Injury, Cerebral Palsy, and Others; End-user: Hospitals/Clinics, Rehabilitation Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Wearable Neurorehabilitation Devices Market Outlook 2031

  • The global industry was valued at US$ 552.8 Mn in 2022
  • It is projected to advance at a CAGR of 13.7% from 2023 to 2031 and reach US$ 1.7 Bn by 2031

Analysts’ Viewpoint

Rise in prevalence of neurological disorders such as stroke, Parkinson's disease, multiple sclerosis, cerebral palsy, traumatic brain injury, and spinal cord injury are driving the global market. Rise in awareness about neurorehabilitation devices among the population is a major factor expected to drive market expansion. Furthermore, increase in investment in R&D on neurorehabilitation products is likely to bolster global wearable neurorehabilitation devices market size in the next few years.

Launch of technologically advanced wearable neurorehabilitation devices offers lucrative offers to market players. Companies are focusing on increasing investment to enhance product offerings and expand global footprint. Post the COVID-19 pandemic, wearable brain neurorehabilitation device manufacturers are investing significantly in the development of advanced devices to increase sales.

Wearable Neurorehabilitation Devices Market

Global Wearable Neurorehabilitation Devices Market Introduction

Wearable neurorehabilitation devices are used to provide biofeedback about biomechanical or physiological body parameters to improve outcomes in people with neurological diseases. This is a promising approach that influences motor learning and patients’ engagement.

Wearable neurorehabilitation devices include force-based sensors, which are the most popular form utilized in wearable sensors for rehabilitation. Several forms of these sensors are used to provide auditory, visual, and biofeedback alongside force-based measurements. Force-based sensors include gyroscopes, accelerometers, and magnetometers.

Rise in prevalence of neurological diseases, such as Parkinson’s disease and stroke, is projected to drive the global wearable neurorehabilitation devices market growth. For instance, the World Health Organization (WHO) projects that by 2030, there will be 103 million patients suffering from neurological illnesses, up from 95 million in 2015.

These numbers highlight the need to reduce the occurrence of these illnesses, which will subsequently increase the requirement for neurorehabilitation equipment. Usage of neurorehabilitation equipment for the diagnosis and treatment of neurological diseases has increased as a result of rise in prevalence of neurological diseases.

According to the WHO, epilepsy is a widespread neurological condition that affects 50 million individuals across the globe (as of 2016), and 2.4 million new cases are reported each year. According to the World Economic Forum, there will be 8.7 million Parkinson's disease patients worldwide by 2030.

Introduction of wearable technology & robots and rise in expenditure on healthcare infrastructure are anticipated to bolster the global neurorehabilitation devices industry. Customers prefer to own a single, small gadget that can fulfil all of their computing and monitoring needs.

Development of innovative wearable neurorehabilitation devices by various companies is fueling market development. However, high cost of neurorehabilitation devices is likely to restrain market growth to some extent.

Research & development in wearable neurorehabilitation devices is anticipated to offer various opportunity to market players during the forecast period. For instance, Hand Extension Robot Orthosis (HERO) Grip Glove, a clinical trial product, was iteratively designed to meet requests from therapists and persons after a stroke who have severe hand impairment. The device extends all five fingers, enhances grip strength, and is portable, lightweight, easy to put on, comfortable and affordable. As per Myomo, Inc., its product MayoPal device is anticipated to launch by 2024 for pediatric patients with upper extremity paralysis.

Pipeline trials were conducted in 2021 for multiple sclerosis (MS) using EKSO GT exoskeleton. EKSO GT is an over-ground wearable exoskeleton developed and commercialized to train and improve gait in people with neurological diseases. This device reproduces physiological gait minimizing compensatory patterns and guiding recovery.

COVID-19 Impact on Wearable Neurorehabilitation Devices Market

The COVID-19 pandemic has had a significant impact on the global market. The pandemic resulted in a temporary decline in the industry, as most healthcare providers redirected resources to prioritize the treatment of COVID-19 patients, leading to reduced demand for wearable neurorehabilitation.

Supply chain disruptions caused challenges in the production and distribution of wearable neurorehabilitation. Manufacturing delays, transportation constraints, and import/export restrictions led to potential shortages and limited availability of these products.

However, the COVID-19 pandemic created new challenges to patient care, imposing adaptation of healthcare facilities such as telemedicine for neurological diseases. Therefore, these efforts in the field of wearable neurorehabilitation devices are expected to fuel market expansion in the post-pandemic period.

Surge in Incidence of Stroke

In terms of application, the stroke segment accounted for the largest global wearable neurorehabilitation devices market share in 2022. The trend is expected to continue during the forecast period. This is ascribed to constant increase in incidence of stroke across the globe.

As per the Global Stroke Factsheet released in 2022, lifetime risk of developing a stroke has increased by 50% over the past 17 years; presently, 1 in 4 people is likely to have a stroke in the lifetime.

Availability of Infrastructure and Resources Propelling Hospitals/Clinics Segment

Based on end-user, the hospitals/clinics segment dominated the global wearable neurorehabilitation devices market in 2022. Hospitals and clinics serve as major healthcare providers and have the infrastructure and resources to perform neurological treatment procedures.

Rehabilitation centers was the second largest segment in 2022. This is ascribed to increase in treatment of neurological disorders, such as stroke, in rehabilitation centers across the globe.

Regional Analysis

As per wearable neurorehabilitation devices market trends, North America accounted for significant share in 2022. This is ascribed to high incidence of stroke and Parkinson’s disease, federal government funding, and investment in diagnosis & prevention of neurodegenerative diseases.

The U.S. and Canada are the major markets in North America. More than 130,000 people die each year in the U.S. due to stroke, and it is the leading cause of disability. Also, more than 400,000 people in Canada are suffering from long-term stroke disability.

North America is home to leading players such as Ekso Bionics Holdings, Inc., Flint Rehab, and Myomo, Inc. Adoption rate of wearable neurorehabilitation devices is expected to increase in the region, as the treatments are covered under the medical insurance plans and the average out-of-pocket expenses are high in the region.

Europe is expected to witness significant wearable neurorehabilitation devices market demand during the forecast period. This is ascribed to rise in patient base with neurological disorders and improving healthcare infrastructure. Moreover, companies are adopting strategic initiatives to expand operations in this region.

Analysis of Key Players

The wearable neurorehabilitation devices market report concludes with the company profiles section that includes key information about the major players. Companies focus on strategies such as new product launches, mergers, and partnerships & collaborations to compete in the marketplace.

Cadence Biomedical, Flint Rehab, Ekso Bionics Holdings, Inc., Myomo, Inc., and ReWalk Robotics are the prominent players in the market.

Key Developments in Global Wearable Neurorehabilitation Devices Market

  • In June 2023, Cala Health launched its next-generation Cala kIQ System, an FDA-cleared wearable device to relieve hand tremors in people with essential tremor and Parkinson’s disease. According to the company, the noninvasive, nonpharmacologic system delivers transcutaneous afferent patterned stimulation (TAPS) therapy with minimal side effects via a device worn on the wrist, providing temporary relief of postural and kinetic tremor symptoms.
  • In September 2019, Flint Rehab, a neuro-rehabilitation device company, launched MiGo ahead of CES 2019. MiGo is the first commercially available wearable activity tracker specifically designed for stroke survivors. The device tracks upper extremity activity-in addition to walking-and is optimized for the movement patterns performed by individuals with stroke. The device is accompanied by a smartphone app that provides motivational support through digital coaching, progressive goal setting, and social networking with other stroke survivors.

Prominent players have been profiled in the wearable neurorehabilitation devices industry research report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.

Global Wearable Neurorehabilitation Devices Market Snapshot

Attribute Details

Size in 2022

US$ 552.8 Mn

Forecast (Value) in 2031

US$ 1.7 Bn

Growth Rate (CAGR)

13.7%

Forecast Period

2023-2031

Historical Data Available for

2017-2021

Quantitative Units

US$ Mn/Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Application
    • Stroke
    • Spinal Cord Injury
    • Cerebral Palsy
    • Others (Parkinson's disease, brachial plexus injury, multiple sclerosis)
  • End-user
    • Hospitals / Clinics
    • Rehabilitation Centers
    • Others (academic & research institute, home settings)

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Cadence Biomedical
  • Flint Rehab
  • Ekso Bionics Holdings, Inc.
  • Myomo, Inc.
  • ReWalk Robotics

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global wearable neurorehabilitation devices market in 2022?

It was valued at US$ 552.8 Mn in 2022.

How big will the wearable neurorehabilitation devices industry be by 2031?

It is projected to reach US$ 1.7 Bn by 2031.

What will be the CAGR of the wearable neurorehabilitation devices business during the forecast period?

It is anticipated to advance at a CAGR of 13.7% from 2023 to 2031.

Which are the major factors driving demand for wearable neurorehabilitation devices?

Rise in prevalence of neurological disorders, technological advancements, and increase in product launches.

What was the share of the leading wearable neurorehabilitation devices segment in 2022?

The stroke segment accounted for more than 40.0% share in 2022.

Which region will account for major share of wearable neurorehabilitation devices sales during the forecast period?

North America is expected to account for the largest share from 2023 to 2031.

Who are the prominent manufacturers of wearable neurorehabilitation devices?

Cadence Biomedical, Flint Rehab, Ekso Bionics Holdings, Inc., Myomo, Inc., and ReWalk Robotics.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Wearable Neurorehabilitation Devices Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, 2017-2031

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Forces Analysis

    5. Key Insights

        5.1. Technological Advancements

        5.2. Regulatory Scenario

        5.3. Reimbursement Scenario

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by Application

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Application, 2017-2031

            6.3.1. Stroke

            6.3.2. Spinal Cord Injury

            6.3.3. Cerebral Palsy

            6.3.4. Others

        6.4. Market Attractiveness Analysis, by Application

    7. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by End-user, 2017-2031

            7.3.1. Hospitals/Clinics

            7.3.2. Rehabilitation Centers

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Wearable Neurorehabilitation Devices Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Application, 2017-2031

            9.2.1. Stroke

            9.2.2. Spinal Cord Injury

            9.2.3. Cerebral Palsy

            9.2.4. Others

        9.3. Market Value Forecast, by End-user, 2017-2031

            9.3.1. Hospitals/Clinics

            9.3.2. Rehabilitation Centers

            9.3.3. Others

        9.4. Market Value Forecast, by Country, 2017-2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Application

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Wearable Neurorehabilitation Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Application, 2017-2031

            10.2.1. Stroke

            10.2.2. Spinal Cord Injury

            10.2.3. Cerebral Palsy

            10.2.4. Others

        10.3. Market Value Forecast, by End-user, 2017-2031

            10.3.1. Hospitals/Clinics

            10.3.2. Rehabilitation Centers

            10.3.3. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Application

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Wearable Neurorehabilitation Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Application, 2017-2031

            11.2.1. Stroke

            11.2.2. Spinal Cord Injury

            11.2.3. Cerebral Palsy

            11.2.4. Others

        11.3. Market Value Forecast, by End-user, 2017-2031

            11.3.1. Hospitals/Clinics

            11.3.2. Rehabilitation Centers

            11.3.3. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Application

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Wearable Neurorehabilitation Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Application, 2017-2031

            12.2.1. Stroke

            12.2.2. Spinal Cord Injury

            12.2.3. Cerebral Palsy

            12.2.4. Others

        12.3. Market Value Forecast, by End-user, 2017-2031

            12.3.1. Hospitals/Clinics

            12.3.2. Rehabilitation Centers

            12.3.3. Others

        12.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Application

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Wearable Neurorehabilitation Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Application, 2017-2031

            13.2.1. Stroke

            13.2.2. Spinal Cord Injury

            13.2.3. Cerebral Palsy

            13.2.4. Others

        13.3. Market Value Forecast, by End-user, 2017-2031

            13.3.1. Hospitals/Clinics

            13.3.2. Rehabilitation Centers

            13.3.3. Others

        13.4. Market Value Forecast, by Country/Sub-region, 2017-2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Application

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by tier and size of companies)

        14.2. Market Share Analysis, by Company (2022)

        14.3. Company Profiles

            14.3.1. Cadence Biomedical

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. Financial Overview

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. Flint Rehab

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. Financial Overview

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

            14.3.3. Ekso Bionics Holdings, Inc.

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Product Portfolio

                14.3.3.3. Financial Overview

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Myomo, Inc.

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. Financial Overview

                14.3.4.4. SWOT Analysis

                14.3.4.5. Strategic Overview

            14.3.5. ReWalk Robotics

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Product Portfolio

                14.3.5.3. Financial Overview

                14.3.5.4. SWOT Analysis

                14.3.5.5. Strategic Overview

    List of Tables

    Table 01: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031

    Table 02: Global Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 03: Global Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031

    Table 04: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 05: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 06: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 07: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 08: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 09: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 10: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 11: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 12: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 13: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 14: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 15: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 16: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 17: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 18: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 02: Global Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031

    Figure 03: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Stroke, 2017-2031

    Figure 04: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Spinal Cord Injury, 2017-2031

    Figure 03: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Cerebral Palsy, 2017-2031

    Figure 04: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Others, 2017-2031

    Figure 05: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 06: Global Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 07: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Hospitals/Clinics, 2017-2031

    Figure 08: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Rehabilitation Centers, 2017-2031

    Figure 09: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Others, 2017-2031

    Figure 10: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by Region, 2022 and 2031

    Figure 11: Global Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Region, 2023-2031

    Figure 12: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 13: North America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country, 2022 and 2031

    Figure 14: North America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country, 2023-2031

    Figure 15: North America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 16: North America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031

    Figure 17: North America Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 18: North America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, End-user, 2023-2031

    Figure 19: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 20: Europe Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 21: Europe Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 22: Europe Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 23: Europe Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031

    Figure 24: Europe Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 25: Europe Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 26: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 27: Asia Pacific Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 28: Asia Pacific Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 29: Asia Pacific Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 30: Asia Pacific Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031

    Figure 31: Asia Pacific Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 32: Asia Pacific Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 33: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 34: Latin America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 35: Latin America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 36: Latin America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application 2022 and 2031

    Figure 37: Latin America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031

    Figure 38: Latin America Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 39: Latin America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, End-user, 2023-2031

    Figure 40: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 41: Middle East & Africa Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 42: Middle East & Africa Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 43: Middle East & Africa Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application 2022 and 2031

    Figure 44: Middle East & Africa Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031

    Figure 45: Middle East & Africa Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 46: Middle East & Africa Wearable Neurorehabilitation Devices Market Attractiveness Analysis, End-user, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved